Your browser doesn't support javascript.
loading
Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi.
Longley, Rhea J; Grigg, Matthew J; Schoffer, Kael; Obadia, Thomas; Hyslop, Stephanie; Piera, Kim A; Nekkab, Narimane; Mazhari, Ramin; Takashima, Eizo; Tsuboi, Takafumi; Harbers, Matthias; Tetteh, Kevin; Drakeley, Chris; Chitnis, Chetan E; Healer, Julie; Tham, Wai-Hong; Sattabongkot, Jetsumon; White, Michael T; Cooper, Daniel J; Rajahram, Giri S; Barber, Bridget E; William, Timothy; Anstey, Nicholas M; Mueller, Ivo.
  • Longley RJ; Population Health and Immunity Division, WEHI, Parkville 3052, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville 3052, VIC, Australia. Electronic address: longley.r@wehi.edu.au.
  • Grigg MJ; Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia.
  • Schoffer K; Population Health and Immunity Division, WEHI, Parkville 3052, VIC, Australia.
  • Obadia T; Institut Pasteur, Université de Paris, Infectious Disease Epidemiology and Analytics G5 Unit, 75015, Paris, France; Institut Pasteur, Université de Paris, Bioinformatics and Biostatistics Hub, 75015, Paris, France.
  • Hyslop S; Population Health and Immunity Division, WEHI, Parkville 3052, VIC, Australia.
  • Piera KA; Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia.
  • Nekkab N; Institut Pasteur, Université de Paris, Infectious Disease Epidemiology and Analytics G5 Unit, 75015, Paris, France.
  • Mazhari R; Population Health and Immunity Division, WEHI, Parkville 3052, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville 3052, VIC, Australia.
  • Takashima E; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan.
  • Tsuboi T; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan.
  • Harbers M; CellFree Sciences Co., Ltd., Yokohama, Japan; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Tetteh K; London School of Hygiene and Tropical Medicine, London, UK.
  • Drakeley C; London School of Hygiene and Tropical Medicine, London, UK.
  • Chitnis CE; Malaria Parasite Biology and Vaccines Unit, Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France.
  • Healer J; Population Health and Immunity Division, WEHI, Parkville 3052, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville 3052, VIC, Australia.
  • Tham WH; Population Health and Immunity Division, WEHI, Parkville 3052, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville 3052, VIC, Australia.
  • Sattabongkot J; Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • White MT; Institut Pasteur, Université de Paris, Infectious Disease Epidemiology and Analytics G5 Unit, 75015, Paris, France.
  • Cooper DJ; Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Rajahram GS; Queen Elizabeth II Hospital, Clinical Research Centre, Kota Kinabalu, Sabah, Malaysia.
  • Barber BE; Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia.
  • William T; Infectious Diseases Society Kota Kinabalu Sabah, Kota Kinabalu Sabah, Malaysia; Gleneagles Hospital, Kota Kinabalu, Sabah, Malaysia.
  • Anstey NM; Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia.
  • Mueller I; Population Health and Immunity Division, WEHI, Parkville 3052, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville 3052, VIC, Australia.
Cell Rep Med ; 3(6): 100662, 2022 06 21.
Article en En | MEDLINE | ID: mdl-35732155
ABSTRACT
Serological markers are a promising tool for surveillance and targeted interventions for Plasmodium vivax malaria. P. vivax is closely related to the zoonotic parasite P. knowlesi, which also infects humans. P. vivax and P. knowlesi are co-endemic across much of South East Asia, making it important to design serological markers that minimize cross-reactivity in this region. To determine the degree of IgG cross-reactivity against a panel of P. vivax serological markers, we assayed samples from human patients with P. knowlesi malaria. IgG antibody reactivity is high against P. vivax proteins with high sequence identity with their P. knowlesi ortholog. IgG reactivity peaks at 7 days post-P. knowlesi infection and is short-lived, with minimal responses 1 year post-infection. We designed a panel of eight P. vivax proteins with low levels of cross-reactivity with P. knowlesi. This panel can accurately classify recent P. vivax infections while reducing misclassification of recent P. knowlesi infections.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium knowlesi / Malaria Vivax / Malaria Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium knowlesi / Malaria Vivax / Malaria Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article